Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 2 296-309, Copyright © 1998 by American Diabetes Association

ARTICLES

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association


OBJECTIVE: Diabetes is a significant public health problem resulting in substantial morbidity and mortality. The objectives of this study were 1) to determine the direct medical and indirect costs attributable to diabetes and 2) to calculate total and per capita expenditures of people with and without diabetes. RESEARCH DESIGN AND METHODS: Direct medical and indirect expenditures attributable to diabetes in 1997 were estimated at $98 billion. Medical expenditures for the treatment of diabetes were estimated for all individuals in the U.S. in 1997 by age-group, sex, race, type of condition, and site of service. Productivity costs due to disability and premature mortality were also estimated for selected patient cohorts. Etiological fractions based on national health care survey data and published literature were used to estimate the proportion of health service utilization and mortality associated with diabetes-related chronic complications and general medical conditions. RESULTS: Direct medical expenditures attributable to diabetes in 1997 totaled $44.1 billion and comprised $7.7 billion for diabetes and acute glycemic care, $11.8 billion due to the excess prevalence of related chronic complications, and $24.6 billion due to the excess prevalence of general medical conditions. The majority of attributable expenditures were for inpatient care (62%), followed by outpatient services (25%) and nursing home care (13%). Two-thirds of all medical costs for diabetes were borne by elderly people. Attributable indirect costs totaled $54.1 billion and comprised $17.0 billion resulting from premature mortality and $37.1 billion from disability. Total medical expenditures incurred by people with diabetes totaled $77.7 billion or $10,071 per capita, compared with $2,669 for people without diabetes. CONCLUSIONS: The economic burden of diabetes mellitus in the U.S. is enormous. Medical innovations that can delay the onset and slow the progression of diabetes have tremendous potential to mitigate the associated clinical and cost repercussions.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 ptjournalHome page
C.-N. Chen, L.-M. Chuang, and Y.-T. Wu
Clinical Measures of Physical Fitness Predict Insulin Resistance in People at Risk for Diabetes
Physical Therapy, November 1, 2008; 88(11): 1355 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 Clin TrialsHome page
K. L Margolis, Lihong Qi, R. Brzyski, D. E Bonds, B. V Howard, S. Kempainen, Simin Liu, J. G Robinson, M. M Safford, L. T Tinker, et al.
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements
Clinical Trials, June 1, 2008; 5(3): 240 - 247.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
J. Bottomley
Economic costs of diabetes in the US in 2007 -- Implications for Europe
The British Journal of Diabetes & Vascular Disease, March 1, 2008; 8(2): 96 - 100.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association
Economic Costs of Diabetes in the U.S. in 2007
Diabetes Care, March 1, 2008; 31(3): 596 - 615.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. P. Kellogg, T. D. Wiggin, D. D. Larkin, J. M. Hayes, M. J. Stevens, and R. Pop-Busui
Protective Effects of Cyclooxygenase-2 Gene Inactivation Against Peripheral Nerve Dysfunction and Intraepidermal Nerve Fiber Loss in Experimental Diabetes
Diabetes, December 1, 2007; 56(12): 2997 - 3005.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller
Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome
Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507.
[Abstract] [Full Text] [PDF]

Home page
 J Public Health (Oxf)Home page
M. De Civita and K. Dasgupta
Using diffusion of innovations theory to guide diabetes management program development: an illustrative example
J. Public Health Med., September 1, 2007; 29(3): 263 - 268.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
B. G. Bradshaw, G. E. Richardson, and K. Kulkarni
Thriving With Diabetes: An Introduction to the Resiliency Approach for Diabetes Educators
The Diabetes Educator, July 1, 2007; 33(4): 643 - 649.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
B. G. Bradshaw, G. E. Richardson, K. Kumpfer, J. Carlson, J. Stanchfield, J. Overall, A. M. Brooks, and K. Kulkarni
Determining the Efficacy of a Resiliency Training Approach in Adults With Type 2 Diabetes
The Diabetes Educator, July 1, 2007; 33(4): 650 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill
Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1728 - H1736.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]

Home page
 American Journal of Medical QualityHome page
D. Jones and W. Curry
Impact of a PDA-Based Diabetes Electronic Management System in a Primary Care Office.
American Journal of Medical Quality, November 1, 2006; 21(6): 401 - 407.
[Abstract] [PDF]

Home page
 Diabetes Spectr.Home page
M. Munshi

Diabetes Spectr, October 1, 2006; 19(4): 218 - 219.
[Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
S. R. Gambert and S. Pinkstaff
Emerging Epidemic: Diabetes in Older Adults: Demography, Economic Impact, and Pathophysiology
Diabetes Spectr, October 1, 2006; 19(4): 221 - 228.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
M. Mauldon, G. D. Melkus, and M. Cagganello
Tomando control: a culturally appropriate diabetes education program for spanish-speaking individuals with type 2 diabetes mellitus--evaluation of a pilot project.
The Diabetes Educator, September 1, 2006; 32(5): 751 - 760.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Med. Inform. Assoc.Home page
S. Shea, R. S. Weinstock, J. Starren, J. Teresi, W. Palmas, L. Field, P. Morin, R. Goland, R. E. Izquierdo, L. T. Wolff, et al.
A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus
J. Am. Med. Inform. Assoc., January 1, 2006; 13(1): 40 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Qual Health ResHome page
J. K. Montez and T. X. Karner
Understanding the Diabetic Body-Self
Qual Health Res, October 1, 2005; 15(8): 1086 - 1104.
[Abstract] [PDF]

Home page
 DiabetesHome page
H.-Y. Lin, Q. Xu, S. Yeh, R.-S. Wang, J. D. Sparks, and C. Chang
Insulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor
Diabetes, June 1, 2005; 54(6): 1717 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Liu, A. R. Dyer, T.-H. Vu, A. Pirzada, L. M. Manheim, W. G. Manning, M. S. Ashraf, D. B. Garside, and M. L. Daviglus
One-Hour Postload Plasma Glucose in Middle Age and Medicare Expenditures in Older Age Among Nondiabetic Men and Women: The Chicago Heart Association Detection Project in Industry
Diabetes Care, May 1, 2005; 28(5): 1057 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Bryer-Ash and A. J. Garber
Point: Inpatient Glucose Management: The emperor finally has clothes
Diabetes Care, April 1, 2005; 28(4): 973 - 975.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
H. J. Harwood Jr., S. F. Petras, D. J. Hoover, D. C. Mankowski, V. F. Soliman, E. D. Sugarman, B. Hulin, Y. Kwon, E. M. Gibbs, J. T. Mayne, et al.
Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase
J. Lipid Res., March 1, 2005; 46(3): 547 - 563.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Del Guerra, R. Lupi, L. Marselli, M. Masini, M. Bugliani, S. Sbrana, S. Torri, M. Pollera, U. Boggi, F. Mosca, et al.
Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
Diabetes, March 1, 2005; 54(3): 727 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. A. Cramer and M. J. Pugh
The Influence of Insulin Use on Glycemic Control: How well do adults follow prescriptions for insulin?
Diabetes Care, January 1, 2005; 28(1): 78 - 83.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J.-L. Chiasson and R. Rabasa-Lhoret
Prevention of Type 2 Diabetes: Insulin Resistance and Beta-Cell Function
Diabetes, December 1, 2004; 53(suppl_3): S34 - S38.
[Abstract] [Full Text] [PDF]

Home page
 Policy Politics Nursing PracticeHome page
J. T. Rocchiccioli and C. R. O'Donoghue
Diabetes Mellitus: Toward a Federal Policy
Policy Politics Nursing Practice, November 1, 2004; 5(4): 237 - 242.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
H. C. Gerstein
Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor
Ann Intern Med, September 21, 2004; 141(6): 475 - 476.
[Full Text] [PDF]

Home page
 QJMHome page
N. Younis, H. Soran, and S. Farook
The prevention of type 2 diabetes mellitus: recent advances
QJM, July 1, 2004; 97(7): 451 - 455.
[Abstract] [Full Text] [PDF]

Home page
 American Journal of Medical QualityHome page
N. A. Maizlish, B. Shaw, and K. Hendry
Glycemic Control in Diabetic Patients Served by Community Health Centers
American Journal of Medical Quality, July 1, 2004; 19(4): 172 - 179.
[Abstract] [PDF]

Home page
 The Diabetes EducatorHome page
R. Thackeray, R. M. Merrill, and B. L. Neiger
Disparities in Diabetes Management Practice Between Racial and Ethnic Groups in the United States
The Diabetes Educator, July 1, 2004; 30(4): 665 - 675.
[PDF]

Home page
 Diabetes CareHome page
D. R. Miller, M. M. Safford, and L. M. Pogach
Who Has Diabetes? Best Estimates of Diabetes Prevalence in the Department of Veterans Affairs Based on Computerized Patient Data
Diabetes Care, May 1, 2004; 27(suppl_2): B10 - B21.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. A. Hayward, T. P. Hofer, E. A. Kerr, and S. L. Krein
Quality Improvement Initiatives: Issues in moving from diabetes guidelines to policy
Diabetes Care, May 1, 2004; 27(suppl_2): B54 - B60.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. L. Maciejewski and C. Maynard
Diabetes-Related Utilization and Costs for Inpatient and Outpatient Services in the Veterans Administration
Diabetes Care, May 1, 2004; 27(suppl_2): B69 - B73.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. T. Sawin, D. J. Walder, D. S. Bross, and L. M. Pogach
Diabetes Process and Outcome Measures in the Department of Veterans Affairs
Diabetes Care, May 1, 2004; 27(suppl_2): B90 - B94.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. Vijan and R. A. Hayward
Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians
Ann Intern Med, April 20, 2004; 140(8): 650 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. P. Guignard, J. Oberholzer, P.-Y. Benhamou, S. Touzet, P. Bucher, A. Penfornis, F. Bayle, L. Kessler, C. Thivolet, L. Badet, et al.
Cost Analysis of Human Islet Transplantation for the Treatment of Type 1 Diabetes in the Swiss-French Consortium GRAGIL
Diabetes Care, April 1, 2004; 27(4): 895 - 900.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
C. A. Witczak and M. Sturek
Exercise prevents diabetes-induced impairment in superficial buffer barrier in porcine coronary smooth muscle
J Appl Physiol, March 1, 2004; 96(3): 1069 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Deng, M. Vatamaniuk, X. Huang, N. Doliba, M.-M. Lian, A. Frank, E. Velidedeoglu, N. M. Desai, B. Koeberlein, B. Wolf, et al.
Structural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects
Diabetes, March 1, 2004; 53(3): 624 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H.-S. Kwon, J.-H. Cho, H.-S. Kim, B.-R. Song, S.-H. Ko, J.-M. Lee, S.-R. Kim, S.-A. Chang, H.-S. Kim, B.-Y. Cha, et al.
Establishment of Blood Glucose Monitoring System Using the Internet
Diabetes Care, February 1, 2004; 27(2): 478 - 483.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. A. Corpus, P. B. George, J. A. House, S. R. Dixon, S. C. Ajluni, W. H. Devlin, G. C. Timmis, M. Balasubramaniam, and W. W. O'Neill
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 8 - 14.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
C. S. Barnes, D. C. Ziemer, C. D. Miller, J. P. Doyle, C. Watkins Jr, C. B. Cook, D. L. Gallina, I. El-Kebbi, W. T. Branch Jr, and L. S. Phillips
Little Time for Diabetes Management in the Primary Care Setting
The Diabetes Educator, January 1, 2004; 30(1): 126 - 135.
[PDF]

Home page
 Diabetes CareHome page
A. Arredondo and A. Zuniga
Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries: The Mexican case
Diabetes Care, January 1, 2004; 27(1): 104 - 109.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. T. Hurst and R. W. Lee
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
Ann Intern Med, November 18, 2003; 139(10): 824 - 834.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. A. Helmer, C.-L. Tseng, M. Brimacombe, M. Rajan, N. Stiptzarov, and L. Pogach
Applying Diabetes-Related Prevention Quality Indicators to a National Cohort of Veterans With Diabetes
Diabetes Care, November 1, 2003; 26(11): 3017 - 3023.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. R. Majumdar, L. M. Guirguis, E. L. Toth, R. Z. Lewanczuk, T.K. Lee, and J. A. Johnson
Controlled Trial of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes
Diabetes Care, November 1, 2003; 26(11): 3061 - 3066.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. M. V. Narayan, J. P. Boyle, T. J. Thompson, S. W. Sorensen, and D. F. Williamson
Lifetime Risk for Diabetes Mellitus in the United States
JAMA, October 8, 2003; 290(14): 1884 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 Med Care Res RevHome page
W. Yu, A. Ravelo, T. H. Wagner, C. S. Phibbs, A. Bhandari, S. Chen, and P. G. Barnett
Prevalence and Costs of Chronic Conditions in the VA Health Care System
Med Care Res Rev, September 1, 2003; 60(3_suppl): 146S - 167S.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
R. W. Grant, H. E. Hamrick, C. M. Sullivan, A. K. Dubey, H. C. Chueh, E. Cagliero, and J. B. Meigs
Impact of Population Management With Direct Physician Feedback on Care of Patients With Type 2 Diabetes
Diabetes Care, August 1, 2003; 26(8): 2275 - 2280.
[Abstract] [Full Text] [PDF]

Home page
 J Transcult NursHome page
C. R. Adams
Lessons Learned from Urban Latinas with Type 2 Diabetes Mellitus
J Transcult Nurs, July 1, 2003; 14(3): 255 - 265.
[Abstract] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. M. Engelgau, K. M. Venkat Narayan, J. B. Saaddine, and F. Vinicor
Addressing the Burden of Diabetes in the 21st Century: Better Care and Primary Prevention
J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S88 - 91.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
S. H. Simpson, P. Corabian, P. Jacobs, and J. A. Johnson
The cost of major comorbidity in people with diabetes mellitus
Can. Med. Assoc. J., June 24, 2003; 168(13): 1661 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
K.-H. Mak and D. P. Faxon
Clinical studies on coronary revascularization in patients with type 2 diabetes
Eur. Heart J., June 2, 2003; 24(12): 1087 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
A. Patel, J. Chalmers, V. Chaturvedi, R. Currie, H. Monaghan, and B. Neal
Diabetes and Vascular Disease: a New International Trial
Asian Cardiovasc Thorac Ann, June 1, 2003; 11(2): 180 - 184.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. W. Grant, N. G. Devita, D. E. Singer, and J. B. Meigs
Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes
Diabetes Care, May 1, 2003; 26(5): 1408 - 1412.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. J. Jiang, D. Stryer, B. Friedman, and R. Andrews
Multiple Hospitalizations for Patients With Diabetes
Diabetes Care, May 1, 2003; 26(5): 1421 - 1426.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Davidson
The Case for "Outsourcing" Diabetes Care
Diabetes Care, May 1, 2003; 26(5): 1608 - 1612.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
S. B. Levy and H. Cohen
Screening, Diagnosis, and Pharmacotherapy for Type 2 Diabetes Mellitus
Journal of Pharmacy Practice, April 1, 2003; 16(2): 127 - 137.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
D. E. Bonds, D. J. Zaccaro, A. J. Karter, J. V. Selby, M. Saad, and D. C. Goff Jr
Ethnic and Racial Differences in Diabetes Care: The Insulin Resistance Atherosclerosis Study
Diabetes Care, April 1, 2003; 26(4): 1040 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. R. Maldonado, E. R. Chong, M. A. Oehl, and A. Balasubramanyam
Economic Impact of Diabetic Ketoacidosis in a Multiethnic Indigent Population: Analysis of costs based on the precipitating cause
Diabetes Care, April 1, 2003; 26(4): 1265 - 1269.
[Abstract] [Full Text] [PDF]